Franklin Covey : Financial Statements - Form 8-K

fc-20220114x8k

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported):

January 14, 2022

FRANKLIN COVEY CO.

(Exact name of registrant as specified in its charter)

Commission File No. 001-11107

Utah		87-0401551
(State or other jurisdiction of incorporation)		(IRS Employer Identification Number)

2200 West Parkway Boulevard

Salt Lake City, Utah 84119-2099

(Address of principal executive offices)(Zip Code)

Registrant's telephone number, including area code: [phone]

Former name or former address, if changed since last report: Not Applicable

______________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[ ]Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ]Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ]Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ]Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $.05 Par Value	FC	New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company □

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. □

‎

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers.

As noted below, on January 14, 2022, the shareholders of Franklin Covey Co. (the Company) approved the Franklin Covey Co. 2022 Omnibus Incentive Plan (the Plan). The Plan was adopted by the Company's Board of Directors on November 12, 2021. With shareholder approval obtained, the Plan is effective as of January 14, 2022. Subject to adjustment in certain circumstances, the Plan authorizes up to 1,000,000 shares of common stock for issuance.

Any employees, officers, consultants, advisors, independent contractors, or non-employee directors of the Company or any of its subsidiaries or affiliates is eligible to receive an award under the Plan. Generally, grants may be made in any of the following forms:

Stock Options

Stock Appreciation Rights

Restricted Stock and Restricted Stock Units

Other Stock-Based Awards

A summary of the Plan appears on pages 47 to 57 of the Company's Proxy Statement as filed with the Securities and Exchange Commission on December 15, 2021 and is incorporated by reference herein. The foregoing description and the summary contained in the Company's Proxy Statement do not purport to be complete and are qualified in their entirety by reference to the full text of the Plan, which is attached hereto as Exhibit 10.1.

Item 5.07 Submission of Matters to a Vote of Security Holders.

The Company held its Annual Meeting of Shareholders on Friday, January 14, 2022. For more information on the following proposals, refer to the Company's Proxy Statement filed with the Securities and Exchange Commission on December 15, 2021, the relevant portions of which are incorporated herein by reference. The matters voted on and the results of the votes are as follows:

1.The following nominees for Director were elected. Each person elected will serve until the next annual meeting of shareholders or until such person's successor is elected and qualified.

4444
Nominee		Number of Votes Cast For		Number of Votes Withheld		Broker Non-Votes
Anne H. Chow		9,147,232		37,880		2,673,115
Craig Cuffie		9,162,683		22,429		2,673,115
Donald J. McNamara		9,074,546		110,566		2,673,115
Joel C. Peterson		9,129,043		56,069		2,673,115
Nancy Phillips		9,148,741		36,371		2,673,115
Derek C.M. van Bever		9,162,708		22,404		2,673,115
Robert A. Whitman		9,026,318		158,794		2,673,115

2.The advisory vote for the approval of executive compensation as described and presented in the Compensation Discussion and Analysis of the Company's Proxy Statement was approved with 8,930,718 votes in favor; 217,878 votes against; and 36,516 abstentions. The number of broker non-votes was 2,673,115.

3.The ratification of the appointment of Deloitte & Touche, LLP as the Company's Independent Registered Public Accounting Firm for the fiscal year ending August 31, 2022 was approved with 11,835,246 votes cast in favor; 2,913 votes against; and 20,068 abstentions. There were no broker non-votes for this proposal.

4.The Franklin Covey Co. 2022 Omnibus Incentive Plan was approved with 8,741,458 votes cast in favor; 428,122 votes against; and 15,532 abstentions. The number of broker non-votes was 2,673,115.

‎

Item 9.01 Financial Statements and Exhibits

(d)	Exhibits
10.1	Franklin Covey Co. 2022 Omnibus Incentive Plan
104	Cover Page Interactive Data File - the cover page XBRL tags are embedded within the inline XBRL document.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

		FRANKLIN COVEY CO.
Date: January 14, 2022		By:	/s/ Stephen D. Young
			Stephen D. Young
			Chief Financial Officer